2m 2m 2m 2m 2m 2m 2m
Neogenomics (NEO)
NASDAQ
$18.58+$0.80 (+4.50%)
Price as of Oct 02, 2026 5:41 PM EDT- $2.3BMarket Cap
- 98.00%1-Year Change
- Diagnostics & ResearchIndustry
Neogenomics (NEO)
$18.58+$0.80 (+4.50%)
NEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.78 | ||
Change | -$0.58 (-3.16%) | ||
Open | $18.18 | ||
High | $18.76 | ||
Low | $17.74 | ||
Previous Close | $18.36 | ||
Volume | 2,470,259 | ||
30-Day Average Volume | 2,065,438 | ||
1-Week Change | -9.10% | ||
1-Month Change | 1.89% | ||
1-Year Change | 98.00% | ||
3-Year Change | 44.55% | ||
5-Year Change | -63.33% | ||
Fundamentals | |||
Shares Outstanding | 128.5M | ||
Total Assets | $1.4B | ||
Market Cap | $2.3B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | $201.7M | ||
Net Income | $2.2M | ||
Free Cash Flow | $11.7M | ||
EBIT | $1.8M | ||
EBITDA | $9.5M | ||
Net Working Capital | $275.6M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 266 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 3 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 195 | ||
Price/Operating Cash Flow | 114 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue